ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Accepts sNDA for Tyvaso from United Therapeutics americanpharmaceuticalreview
August 21, 2020United Therapeutics announced the U.S. Food and Drug Administration (FDA) accepted for review the supplemental New Drug Application (sNDA) for Tyvaso? (treprostinil) Inhalation Solution for the treatment of pulmonary hypertension associated with ...
Pharma Sources Insight January 2025
